🇺🇸 Levodopa / Carbidopa in United States

1,563 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Dyskinesia — 241 reports (15.42%)
  2. Fall — 220 reports (14.08%)
  3. Drug Ineffective — 154 reports (9.85%)
  4. Hallucination — 153 reports (9.79%)
  5. Parkinson^S Disease — 149 reports (9.53%)
  6. Gait Disturbance — 141 reports (9.02%)
  7. On And Off Phenomenon — 131 reports (8.38%)
  8. Fatigue — 129 reports (8.25%)
  9. Tremor — 127 reports (8.13%)
  10. Dizziness — 118 reports (7.55%)

Source database →

Other Neurology approved in United States

Frequently asked questions

Is Levodopa / Carbidopa approved in United States?

Levodopa / Carbidopa does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Levodopa / Carbidopa in United States?

Ross D. Zafonte, MD is the originator. The local marketing authorisation holder may differ — check the official source linked above.